Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VYNE THERAPEUTICS INC.

(VYNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart VYNE THERAPEUTICS INC.
Upcoming events on VYNE THERAPEUTICS INC.
03/03/22 FY 2021 Earnings Release (Projected)
05/05/22 Q1 2022 Earnings Release (Projected)
11/10/22 Q3 2022 Earnings Release (Projected)
03/02/23 FY 2022 Earnings Release (Projected)
Past events on VYNE THERAPEUTICS INC.
01/05/22 LifeSci Partners Corporate Access Event
11/22/21 | 10:00am Piper Sandler Virtual Healthcare Conference - Pre-Recorded
11/10/21 | 08:30am Q3 2021 Earnings Call
11/10/21 | 07:30am Q3 2021 Earnings Release
09/28/21 | 04:00pm Cantor Fitzgerald Global Healthcare Conference
09/13/21 | 07:00am H.C. Wainwright Global Investment Conference - Fireside Chat
08/12/21 | 08:30am Interim 2021 Earnings Call
08/12/21 | 07:30am Interim 2021 Earnings Release
07/19/21 Annual General Meeting
06/30/21 | 02:40pm JAK Inhibitor Drug Development Summit - Panel
Past dividends on VYNE THERAPEUTICS INC.

- No events available -

Annual results
Fiscal Period : December201620172018201920202021
Sales
M $
Released
Forecast
Spread
5,53
4,85
14%
3,67
3,66
0,28%
3,60
3,76
-4,4%
0,44
2,34
-81%
21,0
21,7
-3,3%
 
16,6
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-29,5
-25,8
-14%
-65,4
-62,5
-4,6%
-74,6
-74,2
-0,57%


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-29,7
-27,2
-8,9%
-65,6
-63,9
-2,7%
-74,9
-72,5
-3,3%
-95,9
-99,9
4,0%
-253
-190
-33%
 
-65,9
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-28,9
-25,4
-14%
-64,6
-62,8
-2,8%
-74,0
-72,3
-2,3%
-95,4
-99,3
4,0%
-256
-259
1,0%
 
-69,5
 
Net income
M $
Released
Forecast
Spread
-29,3
-25,0
-17%
-65,7
-63,0
-4,3%
-74,2
-73,0
-1,6%
-95,2
-99,3
4,2%
-256
-258
1,0%
 
-69,5
 
EPS
$
Released
Forecast
Spread


 


 


 


 
-7,88
-6,72
-17%
 
-1,35
 
Announcement Date02/21/201702/27/201802/28/201903/12/202003/04/2021-
Quarterly results
Fiscal Period : December2020 Q32020 Q42021 Q12021 Q22021 Q32021 Q4
Sales
M $
Released
Forecast
Spread
3,27
3,25
0,50%
4,29
4,98
-14%
4,12
4,77
-14%
4,26
6,43
-34%
4,09
4,76
-14%
 
4,12
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-23,5
-26,9
13%
-22,0
-22,3
1,5%
-19,4
-21,0
7,5%
-16,9
-17,7
4,5%
-17,8
-16,1
-11%
 
-13,4
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-24,7
-29,6
16%
-23,2
-24,3
4,7%
-20,6
-23,3
12%
-19,9
-19,9
-0,15%
-21,3
-18,1
-18%
 
-12,1
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-24,7
-29,6
16%
-23,2
-24,4
4,9%
-20,6
-23,3
12%
-19,9
-19,9
-0,15%
-21,3
-18,1
-18%
 
-12,1
 
Net income
$
Released
Forecast
Spread
-0,60
-0,72
17%
-0,55
-0,46
-19%
-0,42
-0,48
13%
-0,39
-0,36
-7,3%
-0,41
-0,32
-28%
 
-0,23
 
Announcement Date11/05/202003/04/202105/06/202108/12/202111/10/2021-
Previous year Next Year
Upcoming sector events for VYNE THERAPEUTICS INC.
More events
Past sector events for VYNE THERAPEUTICS INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise